<DOC>
	<DOCNO>NCT01107405</DOCNO>
	<brief_summary>The purpose study evaluate efficacy loteprednol etabonate ophthalmic base , compare loteprednol etabonate ophthalmic suspension , vehicle prevention sign symptom allergic conjunctivitis modify Conjunctival Allergen Challenge model environmental model pollen season . Comparisons make follow 2 week dose .</brief_summary>
	<brief_title>Loteprednol Ophthalmic Base Compared Loteprednol Ophthalmic Suspension v Placebo Allergen Challenge</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>Positive history ocular allergy positive skin test reaction cat hair , cat dander , grass , ragweed , and/or tree within past 24 month . Calculated bestcorrected visual acuity 0.70 logMAR good eye measure use ETDRS chart . Positive bilateral conjunctival allergen challenge ( CAC ) reaction within 10 minute instillation last titration allergen visit 1 . Positive bilateral CAC reaction 1 3 time point initial rechallenge visit 2 . Known contraindication sensitivity study medication component . Any ocular condition , opinion investigator , could affect subject safety trial parameter . Use disallow medication period indicate prior study enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>